Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GAMT mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of GAMT mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GAMT mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of GAMT mRNA | decreases expression | 19103213
|
D000638 |
Amiodarone |
Amiodarone affects the expression of GAMT mRNA | affects expression | 19483382
|
D000641 |
Ammonia |
Ammonia results in increased expression of GAMT protein | increases expression | 20227315
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GAMT mRNA | affects expression | 16483693
|
D001553 |
Benzbromarone |
Benzbromarone affects the expression of GAMT mRNA | affects expression | 19483382
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in decreased expression of GAMT mRNA | decreases expression | 15912405
|
C032036 |
bromobenzene |
bromobenzene metabolite binds to GAMT protein | affects binding | 17305373
|
D002330 |
Carmustine |
Carmustine results in decreased expression of GAMT mRNA | decreases expression | 15980968
|
D002994 |
Clofibrate |
Clofibrate affects the expression of GAMT mRNA | affects expression | 19483382
|
D003401 |
Creatine |
GAMT protein results in increased chemical synthesis of Creatine | increases chemical synthesis | 18428409
|
D003520 |
Cyclophosphamide |
GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GAMT mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of GAMT mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D005001 |
Ethionine |
Ethionine affects the expression of GAMT mRNA | affects expression | 19483382
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of GAMT protein | increases expression | 15352031
|
D005472 |
Fluorouracil |
GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D005472 |
Fluorouracil |
GAMT protein affects the susceptibility to Fluorouracil | affects response to substance | 15352031
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GAMT mRNA] | affects reaction|decreases expression | 15016801
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of GAMT mRNA | affects cotreatment|increases expression | 17183730
|
D008727 |
Methotrexate |
GAMT protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D009853 |
Omeprazole |
Omeprazole affects the expression of GAMT mRNA | affects expression | 19483382
|
D017239 |
Paclitaxel |
GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C041786 |
palm oil |
palm oil results in increased expression of GAMT mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of GAMT mRNA | increases expression | 12082028
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of GAMT mRNA | decreases expression | 18158353
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GAMT mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GAMT mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GAMT mRNA] | decreases expression|increases reaction | 20059764
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of GAMT mRNA | affects expression | 19483382
|
D011441 |
Propylthiouracil |
Propylthiouracil affects the expression of GAMT mRNA | affects expression | 19483382
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GAMT mRNA | decreases expression | 16960034
|
D013853 |
Thioacetamide |
Thioacetamide affects the expression of GAMT mRNA | affects expression | 19483382
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of GAMT mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
18.06 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
18.06 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
18.06 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
18.06 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.68 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.28 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.86 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.37 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.37 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.59 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.66 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.66 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.66 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.28 | 21441931 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D000592 |
Amino Acid Metabolism, Inborn Errors |
marker/mechanism |
|
| 15651030 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.88 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.88 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.56 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.35 | 17497229 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
8.34 | 18057881 18218290 20041841 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
8.34 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
9.42 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.42 | 15238619 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.03 | 17286800 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.70 | 19698954 18651412 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.40 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Creatine |
2.40 | 16818868 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.40 | 18316065 17688650 17507914 19460635 20603192 18775368 18177632 18940202 16609825 18396377 15238991 19232924 18985861 17157402 18558336 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.73 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.94 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Benzbromarone |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Ethionine |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Omeprazole |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
53.38 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
53.38 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
53.38 | 19483382 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.43 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.43 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.42 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.31 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.26 | 15306635 |
MESH:D001929 |
Brain Edema |
|
Ammonia |
5.99 | 19393034 11481608 20217200 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
8.33 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.33 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
3.58 | 17020986 17388661 15093573 18234424 11325840 16978400 15136595 18323546 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
3.58 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.58 | 18234424 16264153 15634643 16096432 15692762 17426702 15668708 15136595 16322301 19526202 16935488 15939500 15993339 15567936 16595493 18695136 16826403 17983394 15994142 18628466 18382427 16115903 17369602 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.58 | 18608205 16110121 16557594 19217205 18357371 15136595 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
3.58 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
3.58 | 16115903 16244791 11325840 16273361 18234424 15136595 18223236 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.58 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.41 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.41 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.46 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.46 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
21.94 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.94 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
21.94 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Benzbromarone |
21.94 | 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
21.94 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
21.94 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
21.94 | 16332177 16799960 17045692 17971768 18930000 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
21.94 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
21.94 | 1701930 6705139 20007298 17173139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
21.94 | 17997003 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.61 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
14.30 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
14.30 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
14.30 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
14.30 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.57 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.57 | 16757204 17066447 18986760 16280240 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.37 | 17124262 16170337 11754973 17287366 11179087 15728586 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.37 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.35 | 16612575 15476868 17974986 16364871 17924179 17329180 17382496 17308081 16455267 17131338 16278810 18627295 16242529 16651473 17007740 17519947 15792986 17351982 15811867 15505089 16952015 17928571 16269455 16109756 16731534 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.65 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.65 | 16243910 17334414 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.80 | 18974383 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.42 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.14 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
10.14 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.14 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.98 | 4080065 |
MESH:D002637 |
Chest Pain |
|
Omeprazole |
4.82 | 15447763 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.61 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.77 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
8.77 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.20 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.20 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.20 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.19 | 17287894 16340194 17018589 15001691 17016597 18772588 17725105 17172411 16510598 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.40 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.40 | 17255274 16303861 15289873 17594712 18288408 17695437 14970324 16282729 18448328 15148649 18949393 18802399 17094418 18383874 16391804 16331619 20501625 17401013 18509181 17454858 17016601 16524972 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.40 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.69 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.69 | 8888407 16575769 17688650 |
MESH:C535598 |
Creatine deficiency, X-linked |
|
Creatine |
7.15 | 12210795 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.74 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.00 | 19747007 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.70 | 18093676 18372110 15643279 15276878 16413132 10498854 12388444 16614059 11948286 12913760 18710439 16989017 18483878 17010015 17979934 18433785 10700343 18295254 12161096 16651033 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.51 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.65 | 18759878 2524372 12868966 8970840 11298694 8156756 14531868 11906362 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Ammonia |
6.65 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.23 | 2952479 3621924 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.86 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.84 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.13 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.60 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
24.22 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
24.22 | 16192314 7440962 6679447 9022650 18692083 8291058 18289764 9653073 1440618 18648102 11289319 6482804 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
24.22 | 11743745 18071297 12153990 11461765 11739529 11834606 18713872 17906064 14550746 16227642 10663392 11287661 15619225 19085960 12594235 16081117 12540782 14986274 19164858 12705907 17562736 16177239 10774834 12958197 19420014 10915739 19370779 15968718 16485898 17522070 12392966 16109766 19923254 11421492 16393943 14725611 2444490 16781746 11529661 19416960 19739265 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
24.22 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
24.22 | 12628495 10092053 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
24.22 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
24.22 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
24.22 | 12963478 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
24.22 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.81 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.43 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.43 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Omeprazole |
4.06 | 17151854 16613094 15991576 21218061 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
8.16 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
8.16 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
9.58 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
9.58 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.72 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.72 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.62 | 15322242 18230668 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.27 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.87 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.94 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
9.88 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
9.88 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
9.03 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
9.03 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.19 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.19 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
8.09 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.09 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.39 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
10.39 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.55 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
9.55 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.90 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.90 | 16481741 15173087 16785472 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
6.90 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.44 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
27.47 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
27.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
27.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
27.47 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
27.47 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
27.47 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.60 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.86 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.73 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.31 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.13 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
13.13 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.13 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.39 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.94 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
6.98 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.98 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.76 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.23 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.78 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
11.25 | 11014644 15172196 16376943 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
11.25 | 16518429 |
MESH:C537622 |
Guanidinoacetate methyltransferase deficiency |
marker/mechanism |
|
| 15651030 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.30 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.30 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.18 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.29 | 16244371 16879835 12587719 14766674 18674790 16244372 16330681 16495754 16707910 17875725 16144979 18006777 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.48 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.48 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.65 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.14 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.02 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Ammonia |
10.57 | 12420312 16338762 20549931 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
10.57 | 18665440 17276928 15929193 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.25 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.57 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
8.57 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
18.42 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
18.42 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
18.42 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
18.42 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.94 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.94 | 18501091 15147373 17606976 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.59 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.48 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
8.34 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.34 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.94 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.36 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.67 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.97 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
7.97 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.97 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.35 | 16612254 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.30 | 12791704 18502941 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
10.70 | 18020914 17991464 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
10.70 | 8137927 18031379 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.05 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.44 | 7193160 16517039 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
4.44 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.44 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.65 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.65 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.73 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.11 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.11 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.11 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.90 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
15.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.91 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.91 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
15.91 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.84 | 9562676 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Omeprazole |
3.87 | 19248655 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.35 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.87 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.38 | 17658394 17802794 18172266 17008537 17296974 18587576 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.88 | 10373061 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.10 | 16294345 17596541 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.69 | 10052129 11830472 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.31 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.56 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.25 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
10.25 | 14986274 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.25 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.02 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.67 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.67 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.67 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
4.67 | 12891558 16248980 12679928 18458672 16511523 17355460 18395095 16098781 12175628 15095483 15465738 18380797 15288473 15078482 15075984 18031379 12557150 15334695 17127702 18416461 18606216 16343077 18263696 16126171 12085344 15316131 18615449 15716488 16489207 15288472 15362042 11481614 17050028 17629604 14739098 12531686 10677585 11682029 16097051 11172339 17292413 18032466 15474484 18295389 15158331 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.11 | 19460945 11587558 19784758 16610002 19014921 12587719 12969438 16611625 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.11 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
6.11 | 16337175 18374380 15158337 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.83 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
8.83 | 15633222 12479984 17276928 15313186 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
9.78 | 17045692 15113037 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
9.78 | 19073162 8742319 19812893 15975961 19482888 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.78 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
12.70 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
12.70 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
12.70 | 17172636 6150874 1399818 18308698 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.70 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.37 | 17391786 15350150 11989578 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.19 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
17.50 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
17.50 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
17.50 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.27 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.27 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.27 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.51 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
11.61 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.61 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
11.61 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.34 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
13.37 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
13.37 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
13.37 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.29 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
2.86 | 15458769 |
MESH:D008545 |
Melanoma |
|
Carmustine |
5.04 | 12393984 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.04 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.04 | 12040289 12025231 16342250 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
9.92 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.92 | 16388313 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 15651030 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.95 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.50 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.99 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.25 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.42 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.58 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
11.58 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.49 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.23 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.78 | 8888407 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.62 | 12754197 17974566 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.00 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.32 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.32 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.80 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.73 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.20 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.58 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.94 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.94 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
8.94 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
7.54 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
7.54 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.54 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.49 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.52 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.52 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.95 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.65 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.65 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.73 | 15176712 8761367 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.73 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.65 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.61 | 12837982 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.25 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.07 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
4.66 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.19 | 16723640 21332399 18457598 18674790 20518802 17217161 20132043 19632207 11836018 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.19 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.08 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.08 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.43 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.73 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.70 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.08 | 17016548 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.89 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
2.90 | 11161223 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.12 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.12 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
8.14 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.14 | 15113037 16929163 16500647 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.14 | 16965848 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.21 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.19 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.87 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.87 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.19 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.19 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.65 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.53 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.53 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.22 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.22 | 18437689 16868541 15897917 15749863 16729912 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.22 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.22 | 17172428 17136230 16356831 16729912 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
11.24 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
11.24 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.58 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.58 | 17410198 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
5.61 | 12832656 12490602 11597910 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.61 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.78 | 15538739 16160472 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.58 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
9.58 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.25 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.17 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.92 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.75 | 17710206 15625365 15675481 16767912 18313854 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.98 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.51 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 15737665 19110320 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.56 | 16636934 |
MESH:D012640 |
Seizures |
marker/mechanism |
|
| 15651030 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.75 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
8.75 | 3137016 4039156 16876388 11442880 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
8.75 | 16876388 15475178 14763951 3137016 1511512 17978042 11044598 11738929 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.54 | 6407741 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.80 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.42 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.25 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.25 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.29 | 16767912 17203757 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.23 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.57 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.26 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Omeprazole |
4.33 | 18545984 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.67 | 17498489 18567086 16951190 15786421 19084572 16424979 19015929 18396642 17172411 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.67 | 18506536 18396642 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
6.76 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Omeprazole |
6.76 | 16755016 18237397 17977527 10750652 15991576 11906479 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.78 | 12837982 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.77 | 9562676 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.02 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.92 | 19225199 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.53 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.10 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.10 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.42 | 1399818 6582329 3712494 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.42 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
15.42 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
15.42 | 15710170 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.59 | 18020914 19584973 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.75 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.91 | 11989578 17467628 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.95 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.24 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.04 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.04 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
11.04 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.04 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.37 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.04 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.72 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.64 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.70 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.95 | 17678736 16364871 17334414 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.50 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.16 | 17120751 |